NCT00174473View on ClinicalTrials.gov

A Study to Investigate the Pharmacokinetics, Safety and Tolerability of Voriconazole in Children

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

June 30, 2003

Study Completion Date

August 31, 2005

Conditions
Neutropenia
Interventions
DRUG

Voriconazole

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00174473 - A Study to Investigate the Pharmacokinetics, Safety and Tolerability of Voriconazole in Children | Biotech Hunter | Biotech Hunter